Taylor Ben R sold RXRX
December 29, 2025 · Form 4 insider transaction
Taylor Ben R sold 21,383 shares of Recursion Pharmaceuticals, Inc. at $4.18 per share, a transaction worth $89.4K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
21,383
Price
$4.18
Total value
$89.4K
InsiderTaylor Ben R
Role—
SecurityClass A Common Stock
Transaction codeS: Open-market sale
Transaction dateDecember 29, 2025
Filing dateDecember 30, 2025
Shares owned after761,550
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 30, 2025.